Handheld Raman — Identify, Detect, Protect

Identifying Xylazine and Emerging Drug Threats

Serstech Arx mkII

Identifying Xylazine and Emerging Drug Threats

Xylazine, nitazenes, and other emerging substances present new challenges for field identification. Quarterly spectral library updates help keep the Arx mkII current with evolving drug threats.

Xylazine: The Emerging Threat

Xylazine — a veterinary sedative not approved for human use — has increasingly appeared in illicit drug supplies, particularly in combination with fentanyl. Known as "tranq," xylazine complicates overdose response because it does not respond to naloxone. Law enforcement, public health, and harm reduction personnel need reliable field identification tools to detect its presence.

Raman Spectroscopy and Xylazine

Xylazine has a distinct Raman spectral signature. Whether a specific substance can be identified depends on its presence in the instrument's current spectral library. Serstech provides quarterly library updates to address emerging drug threats, including xylazine and its combinations with fentanyl and other opioids. Contact Charlie Six to confirm current library coverage for specific substances of interest.

The Challenge of Mixtures

Xylazine is most commonly encountered in combination with fentanyl and other substances rather than as a pure compound. The Arx mkII's multicomponent identification capability supports presumptive identification of mixture components, which is critical for accurately characterizing complex drug samples encountered in the field.

Other Emerging Drug Threats

The illicit drug supply continues to evolve rapidly. Nitazenes, novel synthetic opioids, and other emerging substances present ongoing identification challenges. The Serstech quarterly library update program is designed to address new threats as they are documented. Agencies with specific emerging-threat identification needs should contact Charlie Six to discuss current library coverage.

Keeping Libraries Current

The Serstech Arx mkII includes manufacturer library updates as part of its warranty and support program. Quarterly updates incorporate newly documented substances and refined spectral data. Keeping the instrument's library current is essential for effective identification of emerging drug threats.

Presumptive Identification — Important Note

Handheld Raman provides presumptive identification results. Whether a specific substance can be identified depends on its presence in the current spectral library. Field results should be followed by laboratory confirmation. Consult your agency's legal and forensic advisors regarding the use of field identification results.

Request a Quote or Demonstration

Fill out the form and a Charlie Six representative will respond within one business day.

Charlie Six — Authorized Serstech Distribution Partner · SDVOSB